Accueil>>Analytical Standards>> Certified Reference Materials>>N-Formylamphetamine (CRM)

N-Formylamphetamine (CRM) (Synonyms: NSC 511083)

Catalog No.GC48953

A Certified Reference Material

Products are for research use only. Not for human use. We do not sell to patients.

N-Formylamphetamine (CRM) Chemical Structure

Cas No.: 22148-75-0

Taille Prix Stock Qté
1mg
163,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

N-Formylamphetamine (CRM) is an analytical reference material that is categorized as an amphetamine. It is an intermediate in the synthesis of amphetamine by the Leuckart reaction and may be found as an impurity in seized amphetamine samples.1 N-Formylamphetamine is also a metabolite of N-cyanomethylmethamphetamine and N-formylmethamphetamine .2 This product is intended for research and forensic applications.

1.Power, J.D., Barry, M.G., Scott, K.R., et al.An unusual presentation of a customs importation seizure containing amphetamine, possibly synthesized by the APAAN-P2P-Leuckart routeForensic Sci.Int.23410-13(2014) 2.Sekine, H., Nagao, S., and Nakahara, Y.Abuse of smoking methamphetamine mixed with tobacco. V. Plasma metabolites of N-cyanomethylmethamphetamine, a pyrolysis product formed by smoking methamphetamine in tobacco, and the species difference between mouse and ratBio.Pharm.Bull.19(6)845-851(1996)

Avis

Review for N-Formylamphetamine (CRM)

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-Formylamphetamine (CRM)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.